|
Volumn 50, Issue 8, 2011, Pages 1494-1504
|
Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis: potential contribution to perturbed angiogenesis and fibrosis.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR;
EPHRIN B2;
EPHRIN RECEPTOR B4;
NEUTRALIZING ANTIBODY;
RECOMBINANT PROTEIN;
SPZ1 PROTEIN, HUMAN;
THROMBOSPONDIN;
THROMBOSPONDIN 2;
TRANSFORMING GROWTH FACTOR BETA;
ARTICLE;
CELL CULTURE;
CELL HYPOXIA;
DERMIS;
DIFFUSE SCLERODERMA;
DRUG EFFECT;
FEMALE;
FIBROBLAST;
FIBROSIS;
GENE EXPRESSION;
GENETICS;
HUMAN;
IMMUNOLOGY;
IN SITU HYBRIDIZATION;
MALE;
METABOLISM;
MIDDLE AGED;
NEOVASCULARIZATION (PATHOLOGY);
PATHOLOGY;
PHYSIOLOGY;
ANTIBODIES, NEUTRALIZING;
BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS;
CELL HYPOXIA;
CELLS, CULTURED;
DERMIS;
EPHRIN-B2;
FEMALE;
FIBROBLASTS;
FIBROSIS;
GENE EXPRESSION;
HUMANS;
IN SITU HYBRIDIZATION;
MALE;
MIDDLE AGED;
NEOVASCULARIZATION, PATHOLOGIC;
RECEPTOR, EPHB4;
RECOMBINANT PROTEINS;
SCLERODERMA, DIFFUSE;
THROMBOSPONDINS;
TRANSFORMING GROWTH FACTOR BETA;
|
EID: 84855719845
PISSN: None
EISSN: 14620332
Source Type: Journal
DOI: 10.1093/rheumatology/keq448 Document Type: Article |
Times cited : (21)
|
References (0)
|